1999
DOI: 10.1590/s0066-782x1999000700009
|View full text |Cite
|
Sign up to set email alerts
|

Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty

Abstract: Factors related to vascular dynamics, such as vanishing platelet thrombi, are likely to play an important role in the genesis of myocardial ischemia and infarction, events rarely found in individuals with ET 2,3 . In this study, a case of anterior acute myocardial infarction (AMI) diagnosed in a patient with known ET is reported. The patient received thrombolytic therapy, followed by successful rescue coronary angioplasty (RCA). Case ReportA 48-year-old white male patient arrived at the Emergency Department (E… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…No specific treatment of ACS, in patients with ET is reported. In the literature, only rare cases of application of conventional treatment or coronary angioplasty are found [ 26 ]. In this case, tirofiban, a GP IIb/IIIa receptor blocker, was preferably used, taking into account the pathophysiology of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…No specific treatment of ACS, in patients with ET is reported. In the literature, only rare cases of application of conventional treatment or coronary angioplasty are found [ 26 ]. In this case, tirofiban, a GP IIb/IIIa receptor blocker, was preferably used, taking into account the pathophysiology of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…In the literature, only rare cases of application of conventional treatment, thrombolytic treatment, or coronary angioplasty are found. 11,13 In this case, tirofiban, a GP IIb/IIIa receptor blocker was preferably used, taking into account the pathophysiology of the disease. There are no reports of the use of tirofiban in cases of ET with NSTEMI.…”
Section: Discussionmentioning
confidence: 99%
“…Fewer than 20 cases of essential thrombocytosis with involvement of coronary arteries leading to acute coronary syndromes or myocardial infarction have been reported [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28]. The association between essential thrombocytosis and coronary artery disease was first reported by Saffitz et al [12].…”
Section: Discussionmentioning
confidence: 99%